Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical News Today (MNT)
Claims that semaglutide microdosing works to maintain weight loss and manage blood sugar are mainly anecdotal and not backed by scientific research.
Clinical Pharmacology April 9th 2025
Verywell Health
A Lilly spokesperson told Verywell that about 10% of people who start taking Zepbound for the first time enroll in the self-pay program. This includes people who previously used compounded tirzepatide.
Clinical Pharmacology April 8th 2025
Cleveland Clinic Journal of Medicine (CCJM)
In the absence of contraindications, metformin should be seriously considered as an off-label initial therapy and as an adjunct to antiobesity medications approved by the US Food and Drug Administration.
Endocrinology, Diabetes, Metabolism April 2nd 2025
“It’s absolutely not nature’s Ozempic and does not work like Ozempic, which is a GLP-1 inhibitor. Manufacturers of these supplements are just kind of creating a hype…”
Clinical Pharmacology March 31st 2025
Although limited research exists that spot reduction—the ability to target fat from a specific area—is possible, it is generally accepted that the best way to lose belly fat is through exercise and overall body fat loss.
Cardiology March 13th 2025
ARREST-AF offers very promising insight into the potential efficacy of complete risk-factor modification.
Cardiology March 11th 2025